Researchers
Lana Castellucci

Lana Castellucci

MD, FRCPC, MSc

Scientist, Inflammation and Chronic Disease

Ottawa Hospital Research Institute

Assistant Professor, Medicine

University of Ottawa

Contact

lcastellucci@ohri.ca

613-737-8899

ORCID 0000-0003-1322-9368

Bio

Dr. Lana Castellucci is an Assistant Professor in the Faculty of Medicine at the University of Ottawa, and an Associate Scientist at The Ottawa Hospital Research Institute. She completed Internal Medicine training at the University of Ottawa, a fellowship in Critical Care Medicine at the University of Calgary, followed by a clinical and research fellowship in Thrombosis with a Masters in Clinical Epidemiology at the University of Ottawa.
Clinical research is focused on hospitalized patients and critically ill patients, particularly in the prevention, diagnosis and management of bleeding and venous thromboembolism.

Research Goals and Interests

Bleeding risk
Venous thrombosis
Anticoagulation reversal strategies

News

Publications

How to deal with interference on heparin anti-Xa activity caused by oral factor FXa inhibitors: communication from the ISTH SSC Subcommittee on Control of Anticoagulation

2025-06-01 Go to publication

Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH

2024-10-01 Go to publication

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism

2022-08-09 Go to publication
View More on ORCiD
Patient-Centered Outcomes Research Institute (PCORI) Grant: Warfarin versus Direct Oral Anticoagulants for Secondary Prevention of Recurrent Venous Thromboembolism: A Randomized Comparative Effectiveness Trial 2017-2021.
Role: Co-Principal Investigator. Co-Principal Investigators: Dr. Tom Ortel and Dr. David Garcia.

Continuing Health Science Education Program (CHSE) Research and Innovation Fund: Social Media for Knowledge Translation and Education 2 (SoME-KTE2): Assessing the feasibility of a novel, online needs assessment project to determine curricular design in the age of social media: 2016. Role: Co-Investigator. Principal Investigator: Dr. Teresa Chan.

ICRH Community Development Grants – Sleep and Circadian Rhythms and Venous Thromboembolic Diseases Clinical Trials Grant: 2015-2020. Role: Co-Applicant. Principal Investigators: Dr. Susan Kahn and Dr. Marc Rodger.

Comparison of Bleeding Between Rivaroxaban and Apixaban (COBBRA): Pilot project funded by CanVECTOR network: 2016-2017. Role: Principal Investigator.

The Ottawa Hospital Department of Medicine – Developmental Research Grant: Apixaban Twice Daily vs Rivaroxaban Once Daily for the Treatment of Acute Venous Thromboembolism. 2015-2016.
Role: Principal Investigator. Co-Investigators: Dr. Marc Rodger and Dr. Alan Karovitch.

The Ottawa Hospital Department of Medicine – Developmental Research Grant: Determining the Safety of Enoxaparin Prophylaxis in Critically Ill Adults with Severe Renal Insufficiency. 2013-2014.
Role: Co-Investigator. Principal Investigators: Dr. Marc Carrier and Dr. Rakesh Patel.

The Ottawa Hospital Department of Medicine – Patient Quality and Safety Grant: Improving the Care of Patients Who Require Temporary Interruption of Anticoagulation.
2012-2013. Role: Co-Investigator. Principal Investigator: Dr. Phil Wells.

Related Research at The Ottawa Hospital